Prognostic Value of Matrix Metalloproteinase 9 (MMP9) in Patients Following Off-Pump Coronary Artery Bypass Grafting
Background: Matrix metalloproteinase 9 (MMP9) has recently emerged as a risk predictor in patients with cardiovascular diseases (CVD). However, little is known regarding the significance of elevated plasma MMP9 levels in patients during the long-term period following myocardial revascularisation. We...
Saved in:
Main Authors: | Mikhail Popov, Siarhei Dabravolski, Vladislav Dontsov, Sergei Vzvarov, Evgeniy Agafonov, Dmitriy Zybin, Olga Radchenkova, Dmitriy Saveliev, Victoria Pronina, Natalia Kashirina, Liudmila Lipatova, Mikhail Peklo, Pavel Rutkevich, Elena Yanushevskaya, Alisa Sokolovskaya, Arkadiy Metelkin, Svetlana Verkhova, Nikita Nikiforov, Dmitriy Shumakov |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/15/6/908 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting Th9 cells in autoimmune diseases: a narrative review
by: Wang-Dong Xu, et al.
Published: (2025-07-01) -
Rare human diseases: 9p deletion syndrome.
by: V. O. Galagan
Published: (2014-09-01) -
Galectin-9 treatment is cytotoxic for B cell lymphoma by disrupting autophagy
by: Lisanne Koll, et al.
Published: (2025-06-01) -
Oracle9i : the complete reference /
by: Loney, Kevin
Published: (2002) -
Effect of atorvastatin and rosuvastatin on the PCSK9 blood concentration in statin-naive patients with atherosclerosis
by: A. Yu. Filatova, et al.
Published: (2019-06-01)